Abstract
Objectives Glucocorticoids, mediated by the activation of the HPA axis, affect metabolic responses, insulin resistance, lipolysis and body fat distribution. Dehydroepiandrosterone-sulfate (DHEA-S) is a hormone produced by the adrenal glands and a precursor of sex hormones. The balance and interaction between cortisol and DHEA-S can significantly affect body composition. This study aimed to investigate the relationship between cortisol and DHEA-S levels, cortisol/DHEA-S ratio, and body composition in Korean men and women.
Methods In total, 802 adults participated in this study between January 2018 and March 2023. Socio-demographic data and lifestyle factors were assessed using questionnaires. Body composition, clinical blood pressure, and metabolic variables, including cortisol and DHEA-S levels, were assessed. Cortisol and DHEA-S scores were analyzed in relation to height, body weight(BW), body mass index(BMI) and waist circumference(WC) according to age and sex.
Results Participants had a mean age of 52.6±11.7 years. Cortisol levels adjusted for age and gender were negatively correlated with BW, WC and BMI. This result was more significant in women than in men. DHEA-S levels were positively correlated with height, BW and WC after adjusting for age. The cortisol/DHEA-S ratio was associated with lower height and BW after adjusting for gender. Logistic regression for cortisol, DHEA-S and the cortisol/DHEA-S ratio in the prediction of central obesity was significant for men after adjusting for age and BMI.
Conclusions Elevated cortisol concentrations are associated with lower adiposity. DHEA-S levels were positively correlated with height and body mass. The prediction of central obesity was associated with cortisol and the cortisol/DHEA-S ratio in men and negatively associated with DHEA-S.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ajou University IRB (AJOUIRB-DB-2025-102)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos